Day : February 27, 2018

Politics

Judge Dismisses Case to Overturn Schedule I Status of Cannabis

Editor
Less than two weeks after hearing oral arguments in the case of Washington v. Sessions, which challenged the federal government’s classification of cannabis as a Schedule 1 drug, a federal judge on Monday dismissed the lawsuit. U.S. District Judge, Alvin Hellerstein, stated that the case turned not on the merits...
Hemp News Market Watch

Cannabis Science Announces Launch of iCannabinoid

Editor
On February 27, 2018, Cannabis Science, Inc., (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announced the beta launch of iCannabinoid, a social media and educational website. iCannabinoid is designed to serve as an information center, resource hub, and support group for those seeking alternative cannabinoid...
CCT Impact Hemp News

Investing in Public Companies that Sell CBD

Editor
Interest in cannabidiol (CBD) has taken off over the past five years since CNN highlighted its promise in the documentary Weed. GW Pharma (NASDAQ: GWPH) has submitted a New Drug Application for its CBD-based Epidiolex (which has received Orphan Drug Status in the European Union) with the FDA. If it...
Hemp News Market Watch

Diamond CBD Generates Over One Million in Sales in 15 days

Editor
PotNetwork Holding (OTC: POTN), and its subsidiary Diamond CBD, Inc., generated over a million dollars in sales in the first two weeks of February. This brings Diamond CBD’s total sales to $3.5M for the first six weeks of 2018. Diamond CBD has launched 15 uniquely marketed product lines such as...
Cannabis News Global Health Hemp News Market Watch

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA)

Editor
On February 27, 2018, GW Pharmaceuticals, PLC (Nasdaq:GWPH) (“GW) announced that the European Medicines Agency (EMA) has granted orphan drug designation for cannabidiol (CBD) for the treatment of tuberous sclerosis (TS). GW has started a Phase 3 clinical trial of Epidiolex® (cannabidiol) as an adjunctive therapy for the treatment of...
CCT Impact Current News Growers

Global Hemp Group, Inc. Pursuing Opportunities in America’s ‘New Billion-Dollar Crop’

Editor
Relaxed U.S. restrictions on hemp production increasingly likely Hemp extraction legislation expected to occur in Canada in mid-to-late 2018 Hemp used in dozens of applications across the industrial spectrum “Soil-to-Shelf” strategy for development of hemp in Canada and the United States If you lived in Jamestown in the late eighteenth...